Sign in
4

Changes in Ownership

CLOVER HEALTH INVESTMENTS, CORP. /DE Filed Acc 0001801170-26-000178

CEO, Counterpart Health sold 24,215 shares at $4.67 ($113,084)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wai Conrad CEO, Counterpart Health 2026-07-15 Sale 10b5-1 −24,215 $4.67 $113,084 1,145,699 D: show line 1 in the form
Open-market sales · 24,215 sh · avg $4.67 · $113,084
Loading xslF345X06/wk-form4_1784235321.xml…